In conclusion, our findings suggested that actein could inhibit breast cancer cells metastasis, which may act through the inhibition of EGFR/AKT and NF-κB signaling, suppressed cell adhesion to ECM proteins as well as the reduction of ECM degradation and CXCR4 expression. The gene discussed is NFKB1; the disease is breast carcinoma.